Loading clinical trials...
Loading clinical trials...
This is multicenter, open-label, randomized, active-controled, phase IV study of local direct intra-tumor injection of rAd-p53 monotherapy, with concurrent chemotherapy , with concurrent radiotherapy,...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shenzhen SiBiono GeneTech Co.,Ltd
NCT07287098 · Breast Neoplasms
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07258836 · Neoplasms, Healthy
NCT07169851 · Nausea, Vomiting, and more
NCT07628998 · Colorectal Neoplasms, Early Detection of Cancer
Department of oral and maxillofacial surgery, Huaxi university of medical science
Chendu, Shichuan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions